BREAKING

Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 21 minutes ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 3 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 3 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 4 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 4 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 4 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 21 minutes ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 3 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 3 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 4 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 4 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 4 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago

ADVERTISEMENT

AlphaGraphs

Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement

Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6 billion, or $1.36 per share. Adjusted EPS dropped 35% to $1.67. The company raised its guidance for the full year of 2020. Reported sales are estimated to come in the […]

$JNJ July 16, 2020 1 min read

Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today.

Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6 billion, or $1.36 per share. Adjusted EPS dropped 35% to $1.67.

The company raised its guidance for the full year of 2020. Reported sales are estimated to come in the range of $79.9-81.4 billion and adjusted EPS is expected to be $7.75-7.95.

Check this space for the transcript of Johnson & Johnson Q2 2020 earnings conference call

Past Performance

ADVERTISEMENT

ADVERTISEMENT